Skip to main content

Advertisement

ADVERTISEMENT

News

InnovaMatrix AC - Convatec 

https://www.convatecgroup.com/media/press-releases/2024/convatec_update_on_innovamatrix_ac_clinical_data/

Convatec is progressing in generating and disseminating clinical evidence for InnovaMatrix AC. Results from the 1st phase of its RWE, including VLUs, DFUs and other indications, will be published in H224 and H125. Its 120-patient clinical study for VLUs is currently recruiting patients.

Advertisement

Advertisement

Advertisement